CME Group plans to launch European dairy futures and options before the end of 2026, subject to all regulatory reviews. Its 19 October announcement covers skimmed milk powder, butter, whey powder and liquid milk.
The practical question is how the contracts would represent regional dairy-price exposure. CME says they would be financially settled, initially tracking EEX indices before a later transition to CME Group indices. The announcement does not establish that this transition has already happened.
The announced design and its limits
| Item | Verified detail |
|---|---|
| Products | European skimmed milk powder, butter, whey powder and liquid milk futures and options. Source |
| Target timing | Before the end of 2026, pending all regulatory reviews. Source |
| Settlement | Financial settlement. Source |
| Initial reference | EEX indices, with a planned transition to CME Group indices. Source |
| Exchange rules | To be listed on and subject to CME rules. Source |
| Unconfirmed here | Completed reviews, final first trading day, contract sizes, margins and live prices. Source |
Different dairy products mean different exposures
Milk powder, butter, whey and liquid milk are not interchangeable products. A contract aimed at one reference market should not automatically be treated as a precise hedge for a different product or commercial agreement.
Financial settlement avoids a physical-delivery obligation under the announced design, but it does not guarantee that gains on a contract will offset a company’s actual costs. The relationship between the reference index and the buyer’s or seller’s own transaction price still matters.
Watch the final specification
Before treating these contracts as available instruments, readers should look for regulatory completion and official trading, expiry and specification notices. The intended benchmark transition also needs its own implementation detail; an announced plan is not completed migration.
CME’s earlier cryptocurrency offerings provide a separate example of why exact contract sizes and terms need checking: see CapKet’s contract explainer. This report does not infer future dairy prices or CME earnings from the product announcement.
Additional official record: CME’s 21 October earnings commentary, page 8. The issuer’s 21 October 2026 earnings commentary, page 8 repeats the conditional tungsten/dairy launch plans; same issuer, not independent corroboration. Observed at 2026-10-22T06:24:11.425Z.
Official evidence and scope
CME Group official document. Source observed at 2026-10-22T06:17:12.063Z. This is an AI-assisted primary-document check, not independent human editorial approval. It is not investment advice.
Recorded source observation: . This is a source-check timestamp, not a market quote or a new article update.